Delivery Order SPE2DB22D9239-SPE2DB25FDJ21

Award Date 4/30/25
Potential Completion Date 5/21/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML pharmaceutical products to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $3,112.22, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing indefinite delivery...
This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $9,336.66 and an ultimate completion date of February 27, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite...
This federal contract award is for the delivery of 4566708653 VABYSMO 6 MG/0.05 ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $15,561.10 and an ultimate completion date of January 3, 2025. The contract is not associated with any set-aside designation. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,667.20 contract is for the delivery of VABYSMO 6MG/0.05ML 1S, a pharmaceutical product, with a completion date of April 29, 2025. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a ceiling value of $6,224.44 for the provision of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery...
This federal contract award, with the ID SPE2DB25D9305|SPE2DB25FQACJ, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, under a firm fixed-price delivery order contract with a ceiling value of $5,833.60 and a performance period through February 21, 2025. The contract is not associated with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,780.55 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,458.40, is a firm fixed-price delivery order for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract has an ultimate completion date of February 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a period of performance through May 20, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDJ21
    Delivery Order

This federal contract award is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,667.20 and is a firm fixed-price delivery order with an ultimate completion date of May 21, 2025. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide.

Generated 8/3/25, 1:29 AM